Analysts Set Align Technology, Inc. (NASDAQ:ALGN) PT at $215.00

Key Points

• Align Technology, Inc. has received a consensus recommendation of "Moderate Buy" from fifteen brokerages, with an average 12-month price target of $215.00.
• The company's CEO, Joseph M. Hogan, recently purchased 7,576 shares at an average price of $131.49 per share, indicating confidence in the company’s future.
• missing EPS of $2.49 for the last quarter, below analyst estimates of $2.57, with a revenue of $1.01 billion.

Shares of Align Technology, Inc. (NASDAQ:ALGN - Get Free Report) have been given an average rating of "Moderate Buy" by the sixteen brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $215.00.

Several equities analysts have recently commented on the stock. Stifel Nicolaus lowered their price target on shares of Align Technology from $275.00 to $200.00 and set a "buy" rating for the company in a research report on Thursday, July 31st. Wells Fargo & Company lowered their price target on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a research report on Thursday, July 31st. Piper Sandler lowered their price target on shares of Align Technology from $250.00 to $190.00 and set an "overweight" rating for the company in a research report on Thursday, July 31st. Evercore ISI upped their price target on shares of Align Technology from $200.00 to $220.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Finally, Zacks Research lowered shares of Align Technology from a "hold" rating to a "strong sell" rating in a research report on Monday.

Insider Transactions at Align Technology

In related news, CEO Joseph M. Hogan bought 7,576 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The stock was purchased at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the transaction, the chief executive officer directly owned 184,945 shares of the company's stock, valued at approximately $24,318,418.05. This represents a 4.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.66% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Align Technology

A number of institutional investors and hedge funds have recently bought and sold shares of ALGN. American Trust bought a new position in shares of Align Technology during the 2nd quarter valued at about $323,000. Orion Porfolio Solutions LLC boosted its position in shares of Align Technology by 4.8% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 3,161 shares of the medical equipment provider's stock valued at $598,000 after purchasing an additional 145 shares in the last quarter. Provident Investment Management Inc. boosted its position in shares of Align Technology by 6.1% during the 2nd quarter. Provident Investment Management Inc. now owns 162,313 shares of the medical equipment provider's stock valued at $30,731,000 after purchasing an additional 9,275 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Align Technology by 17.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 321,897 shares of the medical equipment provider's stock valued at $60,945,000 after purchasing an additional 46,935 shares in the last quarter. Finally, Marex Group plc bought a new position in shares of Align Technology during the 2nd quarter valued at about $954,000. Institutional investors own 88.43% of the company's stock.

Align Technology Stock Up 1.2%

Shares of NASDAQ:ALGN traded up $1.64 on Monday, reaching $134.00. 493,536 shares of the company's stock were exchanged, compared to its average volume of 1,220,859. The firm has a market capitalization of $9.71 billion, a price-to-earnings ratio of 22.61, a PEG ratio of 1.60 and a beta of 1.65. Align Technology has a fifty-two week low of $127.70 and a fifty-two week high of $262.87. The business's 50-day moving average is $168.70 and its two-hundred day moving average is $173.14.

Align Technology (NASDAQ:ALGN - Get Free Report) last issued its earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share for the quarter, missing analysts' consensus estimates of $2.57 by ($0.08). The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a return on equity of 13.36% and a net margin of 11.04%.The firm's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period last year, the company posted $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. Analysts predict that Align Technology will post 7.98 earnings per share for the current fiscal year.

Align Technology declared that its Board of Directors has initiated a share buyback plan on Tuesday, August 5th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the medical equipment provider to reacquire up to 2% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's leadership believes its stock is undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.